Legal Guide
SF-86 Drug Use: How to Disclose Past Use and Mitigate the Impact on Your Security Clearance.
The SF-86 asks about drug use in Section 23. Understanding what it asks, what lookback periods apply, and how to frame your disclosures accurately can protect your clearance eligibility. Answering the drug use questions incorrectly, incompletely, or with the wrong framing creates problems that follow you through every reinvestigation for the next 20 years.
Matthew Thomas, Esq.
Former Marine Judge Advocate · 2× USMC Defense Counsel of the Year
Overview
Section 23 of the SF-86 asks whether you have illegally used any controlled substance in the last seven years. It also asks whether you have ever illegally used a controlled substance while holding a security clearance, while in a position of trust, or while employed by the federal government. These are separate questions with different lookback windows, and getting them confused is one of the most common mistakes applicants make.
The drug use section is where more clearance applicants create unnecessary problems than almost anywhere else on the form. Some people under-disclose because they think occasional marijuana use "doesn't count." Others over-disclose and describe experimentation from 15 years ago that falls outside the lookback window. Both approaches hurt the applicant. Under-disclosure creates a honesty problem if the investigator discovers the use through interviews or records. Over-disclosure raises questions that the adjudicator was not asking and did not need to evaluate.
Federal adjudicative standards under SEAD 4 treat marijuana the same as any other controlled substance, regardless of state legalization. This trips up a significant number of applicants. Marijuana is legal in over 20 states for recreational use and in nearly 40 for medical use. It does not matter. The federal government classifies marijuana as a Schedule I controlled substance. SEAD 4 Guideline H (Drug Involvement and Substance Misuse) makes no exception for state-legal use. If you used marijuana in a state where it was legal, you still must disclose it and it will still be evaluated.
The good news: past drug use does not automatically disqualify you from a security clearance. The adjudicator evaluates each case under the whole-person concept and the specific mitigating conditions listed in SEAD 4 Guideline H. Those mitigating conditions include: the behavior happened so long ago or was so infrequent that it is unlikely to recur; the individual has demonstrated a clear and established pattern of abstinence; and the individual has taken positive steps to reduce or eliminate drug use. Evidence that addresses these specific conditions directly is what moves the adjudication.
Matthew Thomas handles SF-86 drug use consultations for clients nationwide. The consultation covers the same ground every time: a full review of your drug use history, identification of what falls within the lookback period and what does not, specific advice on how to frame each disclosure, and preparation for the subject interview where an investigator will ask follow-up questions about what you wrote on the form. Accuracy matters here more than how the answer looks. An adjudicator trained to evaluate drug use disclosures can tell the difference between an honest, well-framed disclosure and an attempt to minimize.
If you are completing the SF-86 for the first time and your drug use history is straightforward, you may not need an attorney. If you have multiple substances, recent use, use while holding a clearance, use while in a position of trust, or a combination of drug use with other disqualifying factors like financial problems or complex drug misconduct, the consultation is worth the investment. The cost of getting the SF-86 wrong is measured in years of career disruption, not dollars.
Accuracy matters here more than how the answer looks. An adjudicator can tell the difference between an honest disclosure and an attempt to minimize.Matthew Thomas, Esq. — SF-86 Drug Use
What You Need to Know
Read this before you do anything.
01
What drug use questions are on the SF-86?
Section 23 asks two primary drug use questions. First: "In the last seven (7) years, have you illegally used any drugs or controlled substances?" Second: "Have you EVER illegally used or otherwise been involved with a drug or controlled substance while possessing a security clearance other than previously listed?" The second question has no time limit. If you used any controlled substance while holding a clearance at any point in your life, it must be disclosed. These are different questions with different lookback periods. Many applicants conflate them.
02
How to answer SF-86 drug use questions
Step one: identify every instance of drug use that falls within the relevant lookback period. Step two: for each instance, document the substance, approximate dates of use, frequency, and circumstances. Step three: frame each disclosure in terms the adjudicator expects: what happened, how long ago, how frequently, and what has changed since. Step four: if the use falls outside the seven-year lookback but occurred while holding a clearance, disclose it under the "ever" question. Step five: prepare for the subject interview by reviewing exactly what you wrote so your in-person statements match the form.
03
Lookback periods: what the SF-86 actually asks
The standard lookback for general drug use is seven years. The lookback for drug use while holding a security clearance is lifetime (no time limit). The lookback for drug use while in a position of trust is also lifetime. These different windows are listed on the form, but they are easy to miss. An applicant who used marijuana once in college eight years ago does not need to disclose it under the seven-year question. An applicant who used marijuana two years ago while holding a Secret clearance must disclose it under the "ever while holding a clearance" question, and that disclosure carries significantly more weight with the adjudicator.
04
SF-86 marijuana disclosure
Marijuana is the most common drug use disclosure on the SF-86. Federal law classifies marijuana as a Schedule I controlled substance under the Controlled Substances Act, regardless of state law. SEAD 4 Guideline H makes no distinction between marijuana and other controlled substances for adjudicative purposes. If you used marijuana in Colorado or California where it is legal, you still must disclose it. The adjudicator will evaluate it the same way they evaluate any other drug use: recency, frequency, circumstances, and evidence of changed behavior.
05
What adjudicators look for in drug use disclosures
Adjudicators evaluate drug use under SEAD 4 Guideline H using the whole-person concept. The key factors are: how long ago the use occurred, how frequently it occurred, what substances were involved, whether the use happened while holding a clearance or position of trust, and what evidence exists that the behavior has stopped and is unlikely to recur. A single instance of marijuana use in college five years ago with no recurrence is evaluated very differently from weekly use of a harder substance that stopped six months before the application. The mitigating conditions in Guideline H are specific. Your disclosure should address them specifically.
06
How to mitigate drug use on the SF-86
Mitigation under SEAD 4 Guideline H requires demonstrating that the conduct is in the past and unlikely to recur. Specific mitigating conditions include: "the behavior happened so long ago, was so infrequent, or happened under such circumstances that it is unlikely to recur" and "the individual has acknowledged the behavior and provided evidence of actions taken to overcome this problem." In practice, mitigation evidence includes a signed statement of intent to abstain (with acknowledgment that future use is grounds for automatic revocation), documentation of time elapsed since last use, changed living circumstances, and distancing from individuals or environments associated with the use.
07
What happens if you fail to disclose drug use
Failing to disclose drug use on the SF-86 is worse than the drug use itself. An omission discovered during the background investigation, either through subject interviews or interviews with references, creates a Guideline E (Personal Conduct) violation for falsification of a government form. Guideline E violations are among the hardest to mitigate because they go directly to the applicant's honesty and reliability. An adjudicator who might have approved a clearance with disclosed marijuana use five years ago will deny it when the same use was concealed on the form.
08
When you need an attorney for SF-86 drug questions
If your drug use is a single instance of marijuana more than two years ago with no other complicating factors, you likely do not need an attorney. If you have multiple substances, recent use (within the last year), use while holding a clearance, use in combination with other SF-86 issues like financial problems or complex drug misconduct, or if you already submitted an SF-86 with a disclosure you think was incomplete, talk to Matthew before you file or amend. The consultation covers the full scope of your history and produces specific advice on how to frame each disclosure. Schedule a consultation at (910) 939-0263.
How It Works
The process, step by step.
Identify all drug use within the lookback period
Review the last seven years for any illegal drug use. Then review your entire history for any use while holding a security clearance or position of trust. These are separate questions with separate lookback windows. Document each instance with the substance, approximate dates, frequency, and circumstances.
Determine which SF-86 questions apply to your situation
Section 23 contains multiple sub-questions. General use in the last seven years is one question. Use while holding a clearance is a separate question with no time limit. Use while in a position of trust is another. Involvement with drug activity (purchase, sale, manufacture) is another. Map each instance of your drug use to the correct question.
Frame each disclosure for the adjudicator
Describe the use accurately: what substance, when, how often, and under what circumstances. Then frame the mitigation: what has changed, how long you have been abstinent, what steps you have taken to ensure the behavior does not recur. The framing should address the specific mitigating conditions under SEAD 4 Guideline H.
Prepare for the subject interview
After you submit the SF-86, an investigator may schedule a subject interview where they ask follow-up questions about your disclosures. Review exactly what you wrote on the form so your verbal answers match the written record. Inconsistencies between the SF-86 and the subject interview are documented and raise additional concerns.
Consult an attorney for complex situations
If your drug use history involves multiple substances, recent use, use while cleared, or overlaps with other SF-86 issues, an attorney review before submission can prevent a denial. Matthew Thomas handles SF-86 drug use consultations for clients nationwide. The consultation produces specific, line-by-line advice on how to answer Section 23.
In This Guide
Section 01
How the SF-86 Drug Use Questions Are Structured
The SF-86 drug use section (Section 23 in the current version) contains a series of questions organized by substance type and time window. Questions ask whether you have used specific controlled substances (marijuana, cocaine, amphetamines, opioids, and others) within defined time periods: typically within the last 7 years and, for some questions, ever.
Each question also asks whether you have ever been involved in the purchase, transfer, distribution, or manufacture of illegal drugs. These questions carry a different weight than personal use questions because they suggest conduct that goes beyond personal choice. If the answer to any purchase/distribution question is yes, disclose it and explain the full context with counsel involved.
The SF-86 also contains questions about drug use while holding a clearance or in a position of trust. Use that occurred after the person already held a clearance is evaluated differently, and more seriously, than use that preceded the clearance application.
Section 02
The Two Biggest Mistakes in SF-86 Drug Disclosure
Mistake one: underreporting. Answering 'no' when the truthful answer is 'yes', or minimizing the frequency and duration of use, is the single most damaging thing an applicant can do. If the investigation surfaces conduct that was not disclosed, the applicant now faces both the underlying conduct issue and a lack-of-candor finding. Lack of candor is one of the hardest adjudicative concerns to mitigate because it goes to fundamental trustworthiness.
Mistake two: overreporting in a way that creates more issues than it resolves. The SF-86 asks specific questions with specific time windows. It does not ask for a complete drug history going back to age 16. Answering questions that weren't asked, or volunteering conduct outside the applicable windows without framing, can create confusion and unnecessary adjudicative flags. The goal is accurate disclosure within the question's scope, not a confessional narrative.
The right approach is precise, honest, complete disclosure within the scope of each question. No more and no less. That sounds simple but requires attention to the exact question being asked, the applicable time window, and how the conduct is described. Matthew advises clients on SF-86 completion specifically because the framing matters as much as the content.
Adjudicators Can Detect Inconsistency
If your SF-86 says 'used marijuana once in college' but your investigation produces references who describe regular use throughout your twenties, you now have a lack-of-candor issue on top of the drug use. Accuracy and consistency across your SF-86, your investigation interviews, and any SOR response matters more than the underlying conduct in many cases.
Section 03
How Adjudicators Evaluate Drug Disclosure
Drug use on the SF-86 is evaluated under SEAD-4 Guideline H (Drug Involvement). Adjudicators look at: the type of drug, the frequency and duration of use, whether use was during a clearance or in a position of trust, the recency of use, whether the person has stopped, and whether the disclosure was candid. The whole-person principle applies; a single use of marijuana five years ago with no recurrence is evaluated very differently from regular cocaine use that continued through the past year.
Mitigation carries real weight under Guideline H. Evidence that use has stopped, that there is a demonstrated passage of time without recurrence, that the person understands the implications for national security, and that there are no other adjudicative concerns in the record can make a meaningful difference in cases involving past use that has genuinely ended.
Section 04
What to Do If You Already Submitted an Inaccurate SF-86
If you submitted an SF-86 that was inaccurate (whether by omission, minimization, or outright inaccuracy) the situation is recoverable in many cases, but it requires careful handling. The approach depends on where you are in the process: pre-investigation, during investigation, or post-SOR.
In all cases, the analysis starts with the same question: what does the investigation likely know or will likely surface? Proactive correction is treated differently than a forced admission after the investigation has already surfaced the discrepancy. Matthew advises clients on exactly this analysis.
Proactive Correction Is Treated Better Than Forced Admission
Addressing an SF-86 inaccuracy proactively, before the investigation surfaces it, is viewed more favorably than an admission extracted by the investigation. If you know your SF-86 was inaccurate, contact an attorney before the investigation progresses.
Common Questions
Frequently Asked Questions
Yes. The SF-86 asks about illegal drug use under federal law. Marijuana remains federally illegal regardless of state law. If your use falls within the applicable disclosure window, you must disclose it. The legal status under state law does not change the federal disclosure obligation.
It depends on whether the use falls within the applicable question's time window. The SF-86 questions have specific lookback periods. If the use falls outside the applicable window, you may not be obligated to disclose it in response to that question. Read the exact question carefully or consult with an attorney before answering.
Yes. Pre-submission SF-86 consultations are available as paid 60-minute consultations. Getting the framing right before submission is far less expensive and less stressful than responding to an SOR after the investigation has surfaced an inconsistency.
Two Ways to Start
Questions About Your Specific Situation?
This guide covers the general principles. Every case has unique facts. Need ongoing support? Matthew Thomas offers a free 15-minute call. No charge, confidential.
All other matters · Paid
